Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease
- Conditions
- AnxietyDepressionParkinson's DiseaseInsomnia
- Interventions
- Behavioral: ICONTROLBehavioral: ICBT
- Registration Number
- NCT01545414
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety symptoms. All treatment in this project is given as an adjunct to Standard Medical Treatment (SMT). ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to SMT alone. It is hypothesized that both active treatments will be superior to SMT, and that ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- Clinical diagnosis of Parkinson's Disease
- At least mild to moderate depression or anxiety defined as HADS-A or HADS-D > 7
- Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview
- Somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders or bipolar disorder)
- Difficulties that hamper the use of a computer
- The patient states difficulties in finding enough time for treatment
- Too low cognitive functioning defined as MoCA < 24
- Too severe depression, defined as MADRS-S over 30
- Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or according to the structured assessment interview
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ICONTROL ICONTROL Internet-based treatment with a focus on relaxation training ICBT ICBT Internet-based Cognitive Behavioral Therapy with a focus on behavioral activation
- Primary Outcome Measures
Name Time Method Change (from baseline) in HADS 12 weeks (Post), 3 and 6 months (FU) Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression
- Secondary Outcome Measures
Name Time Method Change (from baseline) in MADRS-S 12 weeks (Post), 3 and 6 months (FU) Montgomery and Asberg Depressions Rating Scale - Self report, to measure level of depression
Change (from baseline) in ISI 12 weeks (Post), 3 and 6 months (FU) Insomnia Severity Index - self-report, to measure insomnia symptoms
Change (from baseline) in PDQ-8 12 weeks (Post), 3 and 6 months (FU) The Parkinson's Disease Questionnaire-8, to measure various health aspects specific for PD patients
Change (from baseline) in NMSQuest 12 weeks (Post), 3 and 6 months (FU) Non-Motor Symptoms Questionnaire, to measure the non-motor symptoms in PD
Change (from baseline) in EQ-5D 12 weeks (Post), 3 and 6 months (FU) EQ-5D, to measure general health and quality of life
Change (from baseline) in SDS 12 weeks (Post), 3 and 6 months (FU) Sheehan Disability Scale, to measure everyday level of functioning
Trial Locations
- Locations (1)
Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO
🇸🇪Stockholm, Sweden